Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, contro...

por Tricou, Vianney, Essink, Brandon, Ervin, John E., Turner, Mark, Escudero, Ian, Rauscher, Martina, Brose, Manja, Lefevre, Inge, Borkowski, Astrid, Wallace, Derek
Publicado 2023

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

por Gurwith, Marc, Lock, Michael, Taylor, Eve M, Ishioka, Glenn, Alexander, Jeff, Mayall, Tim, Ervin, John E, Greenberg, Richard N, Strout, Cynthia, Treanor, John J, Webby, Richard, Wright, Peter F
Publicado 2013

A Randomized Clinical Trial to Evaluate Two Doses of an Intra-Articular Injection of LMWF-5A in Adults with Pain Due to Osteoarthritis of the Knee

por Bar-Or, David, Salottolo, Kristin M., Loose, Holli, Phillips, Matthew J., McGrath, Brian, Wei, Nathan, Borders, James L., Ervin, John E., Kivitz, Alan, Hermann, Mark, Shlotzhauer, Tammi, Churchill, Melvin, Slappey, Donald, Clift, Vaughan
Publicado 2014

2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level

por Comeaux, Christy A, Falsey, Ann R, Williams, Kristi, Bart, Stephan, Ervin, John E, Bastian, Arangassery R, Menten, Joris, De Paepe, Els, Vandenberghe, Sjouke, Chan, Eric K H, Sadoff, Jerald, Douoguih, Macaya, Callendret, Benoit, Heijnen, Esther
Publicado 2022

LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A R...

por Falsey, Ann R, Williams, Kristi, Gymnopoulou, Efi, Bart, Stephan A, Ervin, John E, Bastian, Arangassery Rosemary, Menten, Joris, De Paepe, Els, de Boer, Hilde, Vandenberghe, Sjoukje, Chan, Eric, Sadoff, Jerald, Douoguih, Macaya, Callendret, Benoit, Comeaux, Christy, Heijnen, Esther
Publicado 2021

96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults ≥ 60 Years of Age: Results at...

por Schwarz, Tino F, Hwang, Shinn-Jang, Ylisastigui, Pedro P, Liu, Chiu-Shong, Takazawa, Kenji, Yono, Makoto, Ervin, John E, Andrews, Charles, Fogarty, Charles, Eckermann, Tamara, Collete, Delphine, de Heusch, Magali, Schrevel, Nathalie De, Salaun, Bruno, Lievens, Marc, Maréchal, Céline, Nakanwagi, Phoebe, Hulstrøm, Veronica
Publicado 2022

571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster

por Tebas, Pablo, Agnes, Joseph, Giffear, Mary, Kraynyak, Kimberly A, Blackwood, Elliott, Amante, Dinah, Reuschel, Emma, Liu, Neiman, Purwar, Mansi, Christensen-Quick, Aaron, Andrade, Viviane M, Carter, Julie, Garufi, Gabriella, Diehl, Malissa, Sylvester, Albert, Morrow, Matthew P, Pezzoli, Patrick P, Kulkarni, Abhijeet J, Zaidi, Faraz I, Frase, Drew, Liaw, Kevin, Patel, Ami, Buttigieg, Karen R, Ervin, John E, Pawlicki, Jan, Gillespie, Elisabeth, Maricic, Igor, Schultheis, Katherine, Badie, Hedieh, Herring, Timothy A, Simon, Keiko O, Smith, Trevor R F, Ramos, Stephanie, Spitz, Robert, Lee, Jessica, Dallas, Michael, Brown, Ami Shah, Shea, Jacqueline E, Kim, J Joseph, Weiner, David, Broderick, Kate, McMullan, Trevor, Boyer, Jean, Humeau, Laurent, Mammen Jr., Mammen P
Publicado 2021